These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1234013

  • 21. A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients.
    Bellamy D, Penketh A.
    Postgrad Med J; 1987 Jun; 63(740):459-61. PubMed ID: 3432172
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF, Grant IW, Pocock SJ.
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe?
    Douglas JG, Rafferty P, Fergusson RJ, Prescott RJ, Crompton GK, Grant IW.
    Thorax; 1985 Mar; 40(3):180-3. PubMed ID: 3983885
    [Abstract] [Full Text] [Related]

  • 31. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols.
    Vidgren P, Silvasti M, Vidgren M, Paronen P, Tukiainen H, Lehti H.
    Pharmazie; 1991 Jan; 46(1):41-3. PubMed ID: 1857729
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.
    Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG.
    Eur J Clin Pharmacol; 1989 Jan; 37(6):567-71. PubMed ID: 2693116
    [Abstract] [Full Text] [Related]

  • 33. Determination of the optimum dose of subcutaneous salbutamol in asthmatic patients.
    Coady TJ, Stewart CJ, Davis HJ.
    Br J Clin Pharmacol; 1976 Apr; 3(2):239-42. PubMed ID: 788745
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients.
    Rodríguez Vázquez JC, Pino Alfonso PP, Gassiot Nuño C, Paez Prats I, Fernández Manzano E.
    J Investig Allergol Clin Immunol; 1998 Apr; 8(2):115-8. PubMed ID: 9615306
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High-dose MDI salbutamol treatment of asthma in the ED.
    Rodrigo C, Rodrigo G.
    Am J Emerg Med; 1995 Jan; 13(1):21-6. PubMed ID: 7832947
    [Abstract] [Full Text] [Related]

  • 40. Intramuscular salbutamol in treatment of acute exacerbations of childhood asthma.
    Thompson P, Friedman M.
    Arch Dis Child; 1977 Jul; 52(7):551-4. PubMed ID: 327944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.